newsMar 21, 202523:26pending
The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray
About this episode
After it was approved in 2019, Spravato, a depression treatment derived from the club drug ketamine, was looking like a dud. But recently it has taken off, and it surpassed $1 billion in annual sales last year for its maker, Johnson and Johnson.
Further Listening:
-A Lawyer Says He Doesn't Need Help for Psychosis. His Family Disagrees.
-America's Maternal Mental Health Crisis
Further Reading:
-J&J’s Ketamine-Derived Drug Is Taking Off
-Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get every episode summarized
Each time The Journal. publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
